New schizophrenia shot could replace daily pills
NCT ID NCT06315283
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new long-acting olanzapine injection (TV-44749) against the standard oral olanzapine pill in 153 people with schizophrenia. The goal was to see if the shot delivers similar drug levels and is safe. Participants received multiple doses over 21 weeks, with researchers measuring how well the body absorbs the drug and tracking side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Teva Investigational Site 15737
Marlton, New Jersey, 08053, United States
-
Teva Investigational Site 15738
Hollywood, Florida, 33024, United States
-
Teva Investigational Site 15739
Los Alamitos, California, 90720, United States
-
Teva Investigational Site 15740
Torrance, California, 90504, United States
-
Teva Investigational Site 15741
Atlanta, Georgia, 30331, United States
-
Teva Investigational Site 15742
Decatur, Georgia, 30030, United States
-
Teva Investigational Site 31326
Zamora, 49021, Spain
-
Teva Investigational Site 34310
Surrey, KT22 7AD, United Kingdom
-
Teva Investigational Site 60053
Zagreb, 10090, Croatia